YEWB — Yew Bio-Pharm Cashflow Statement
0.000.00%
Last trade - 00:00Basic MaterialsHighly SpeculativeMicro Cap
- $0.01m
- $8.98m
- $27.31m
Annual cashflow statement for Yew Bio-Pharm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.01 | 3.21 | -1.32 | 0.986 | 1.46 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.48 | 2.25 | 9.07 | 7.03 | 11.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.8 | -11.8 | 13.7 | 2.11 | 1.99 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.643 | -2.62 | 32.5 | 12 | 17.3 |
| Capital Expenditures | -0.062 | -0.799 | -32.8 | -14.7 | -12.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.296 | 0 | — | 0.013 | -4.59 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.235 | -0.799 | -32.8 | -14.7 | -17.4 |
| Financing Cash Flow Items | -0.049 | -0.171 | 0 | 0.059 | 0.026 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.26 | 3.92 | 0.026 | 2.9 | -0.014 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.403 | 0.581 | -0.338 | 0.221 | -0.178 |